JP2011515672A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011515672A5 JP2011515672A5 JP2011500224A JP2011500224A JP2011515672A5 JP 2011515672 A5 JP2011515672 A5 JP 2011515672A5 JP 2011500224 A JP2011500224 A JP 2011500224A JP 2011500224 A JP2011500224 A JP 2011500224A JP 2011515672 A5 JP2011515672 A5 JP 2011515672A5
- Authority
- JP
- Japan
- Prior art keywords
- marker
- markers
- polypeptide marker
- polypeptide
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 13
- 239000003550 marker Substances 0.000 claims 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 229920001184 polypeptide Polymers 0.000 claims 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- 208000026980 Renal tubular disease Diseases 0.000 claims 4
- 208000014318 renal tubule disease Diseases 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 3
- 238000013508 migration Methods 0.000 claims 3
- 230000005012 migration Effects 0.000 claims 3
- 238000005251 capillar electrophoresis Methods 0.000 claims 2
- 238000004949 mass spectrometry Methods 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 claims 1
- 238000001616 ion spectroscopy Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08153007.3 | 2008-03-19 | ||
| EP08153007 | 2008-03-19 | ||
| EP08167429.3 | 2008-10-23 | ||
| EP08167429 | 2008-10-23 | ||
| PCT/EP2009/053242 WO2009115570A2 (de) | 2008-03-19 | 2009-03-19 | Verfahren und marker zur diagnose von tubulären nierenschäden und -erkrankungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011515672A JP2011515672A (ja) | 2011-05-19 |
| JP2011515672A5 true JP2011515672A5 (https=) | 2012-05-17 |
Family
ID=40671165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011500224A Pending JP2011515672A (ja) | 2008-03-19 | 2009-03-19 | 腎尿細管の損傷および疾患の診断のための方法およびマーカー |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20120037507A9 (https=) |
| EP (1) | EP2255203A2 (https=) |
| JP (1) | JP2011515672A (https=) |
| WO (1) | WO2009115570A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060286602A1 (en) * | 2004-05-10 | 2006-12-21 | Harald Mischak | Method and markers for the diagnosis of renal diseases |
| JP5351773B2 (ja) * | 2007-03-07 | 2013-11-27 | モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト | 尿試料中の検体の濃度を正規化するための方法 |
| EP1972940A1 (de) * | 2007-03-14 | 2008-09-24 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Nierenerkrankungen |
| WO2009047280A2 (de) * | 2007-10-09 | 2009-04-16 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptidmarker zur diagnose von prostatakrebs |
| EP2051078A1 (de) * | 2007-10-19 | 2009-04-22 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Diabetes Mellitus |
| EP2338054A1 (de) * | 2008-09-17 | 2011-06-29 | Mosaiques Diagnostics And Therapeutics AG | Nierenzellkarzinom |
| AU2010267972A1 (en) * | 2009-07-02 | 2012-01-19 | Mosaiques Diagnostics And Therapeutics Ag | Method and markers for diagnosing acute renal failure |
| WO2011152339A1 (ja) * | 2010-05-31 | 2011-12-08 | Tanaka Noriaki | 慢性腎臓病の病期を判定する方法又は装置若しくはその作動方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6372249B1 (en) * | 1991-12-16 | 2002-04-16 | Baylor College Of Medicine | Senscent cell-derived inhibitors of DNA synthesis |
| US6218122B1 (en) * | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| ATE376187T1 (de) * | 1998-12-21 | 2007-11-15 | Univ Monash | Nachweis von erkrankungen der nieren und behandlung |
| US6677114B1 (en) * | 1999-04-20 | 2004-01-13 | Target Discovery, Inc. | Polypeptide fingerprinting methods and bioinformatics database system |
| DE10021737C2 (de) * | 2000-05-04 | 2002-10-17 | Hermann Haller | Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird |
| DE60133558D1 (de) * | 2000-07-12 | 2008-05-21 | Werner Naser | Direkte bestimmung des quotients von analyt- zu referenzmolekülen |
| US20030003588A1 (en) * | 2001-06-28 | 2003-01-02 | Comper Wayne D. | Method for kidney disease detection by protein profiling |
| DE10304106A1 (de) * | 2003-01-31 | 2004-08-26 | Mosaiques Diagnostics And Therapeutics Ag | Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird |
| US7425700B2 (en) * | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| DE10341193A1 (de) * | 2003-09-06 | 2005-03-31 | Mosaiques Diagnostics And Therapeutics Ag | Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen |
| US20050244973A1 (en) * | 2004-04-29 | 2005-11-03 | Predicant Biosciences, Inc. | Biological patterns for diagnosis and treatment of cancer |
| US20060286602A1 (en) * | 2004-05-10 | 2006-12-21 | Harald Mischak | Method and markers for the diagnosis of renal diseases |
| DK2299275T3 (en) * | 2004-07-30 | 2018-05-07 | Adeza Biomedical Corp | Classification of oncofetal fetronectin level for pregnancy-related indications |
| WO2006106129A2 (de) * | 2005-04-07 | 2006-10-12 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptidmarker zur diagnose von prostatakrebs |
| EP1757939A1 (de) * | 2005-08-26 | 2007-02-28 | mosaiques diagnostics and therapeutics AG | Polypeptidmarker zur Diagnose von Blasenkrebs |
| JP2009517677A (ja) * | 2005-11-30 | 2009-04-30 | モザイク・ダイアグノステイツクス・アンド・テラピユーテイツクス・アー・ゲー | 腎盂尿管移行部の診断及び評価用のポリペプチドマーカー |
| BRPI0621006A2 (pt) * | 2006-01-20 | 2011-11-29 | Mosaiques Diagnostics & Therap | método e marcadores para o diagnóstico de doenças renais |
| JP5351773B2 (ja) * | 2007-03-07 | 2013-11-27 | モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト | 尿試料中の検体の濃度を正規化するための方法 |
| EP1972940A1 (de) * | 2007-03-14 | 2008-09-24 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Nierenerkrankungen |
| WO2009047280A2 (de) * | 2007-10-09 | 2009-04-16 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptidmarker zur diagnose von prostatakrebs |
| EP2051078A1 (de) * | 2007-10-19 | 2009-04-22 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Diabetes Mellitus |
| EP2338054A1 (de) * | 2008-09-17 | 2011-06-29 | Mosaiques Diagnostics And Therapeutics AG | Nierenzellkarzinom |
| EP2394171A2 (de) * | 2008-12-17 | 2011-12-14 | mosaiques diagnostics and therapeutics AG | Autosomal dominante polyzystische nierenerkrankung (adpkd) |
| AU2010267972A1 (en) * | 2009-07-02 | 2012-01-19 | Mosaiques Diagnostics And Therapeutics Ag | Method and markers for diagnosing acute renal failure |
| EP2478377A2 (de) * | 2009-09-14 | 2012-07-25 | Mosaiques Diagnostics And Therapeutics AG | Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen |
-
2009
- 2009-03-19 US US12/933,026 patent/US20120037507A9/en not_active Abandoned
- 2009-03-19 EP EP09722298A patent/EP2255203A2/de not_active Withdrawn
- 2009-03-19 WO PCT/EP2009/053242 patent/WO2009115570A2/de not_active Ceased
- 2009-03-19 JP JP2011500224A patent/JP2011515672A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011515672A5 (https=) | ||
| Gould et al. | Breath analysis for detection of viral infection, the current position of the field | |
| JP2017106933A5 (https=) | ||
| Arter et al. | Virus–polymer hybrid nanowires tailored to detect prostate-specific membrane antigen | |
| JP2015503917A5 (https=) | ||
| JP2016105097A5 (https=) | ||
| van Dijk et al. | Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach | |
| JP2016516735A5 (https=) | ||
| JP2012249614A5 (https=) | ||
| WO2012017466A8 (en) | Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof | |
| WO2007117444A3 (en) | Protein detection by aptamers | |
| JP2014144959A5 (https=) | ||
| JP2016224039A5 (https=) | ||
| JP2019524884A5 (https=) | ||
| JP2010207229A5 (https=) | ||
| Leung et al. | Ovarian cancer biomarkers: current state and future implications from high-throughput technologies | |
| JP2013527437A5 (https=) | ||
| JP2015521728A5 (https=) | ||
| JP2012100636A5 (https=) | ||
| JP2018004657A5 (https=) | ||
| WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
| WO2011109112A3 (en) | Method of detecting tau protein and tau fragments in serum | |
| JPWO2019117269A1 (ja) | 膵がんの検出を補助する方法 | |
| RU2018104707A (ru) | ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА | |
| RU2008111496A (ru) | Полипептидные маркеры для диагностики рака мочевого пузыря |